Skip to main content
A quant shop's stocks and options workflow, simplified into one desk.

Research workflow

Turn scattered trading research into an inspectable process.

Serious traders rarely lose time because they have too little information. The harder problem is continuity: the idea, scan, chart work, notes, diagnostics, and follow-up context often live apart. PredictDesk is built to bring that work into one research desk before capital is at risk.

Idea

Start with the setup a trader actually wants to test.

A repeatable workflow starts with a clear research question. PredictDesk is built around defining the setup first so the scan, diagnostics, and follow-up review have something coherent to evaluate.

  • Clarify the market idea before chasing symbols.
  • Keep the objective, horizon, and guardrails attached.
  • Make the workflow answer a trader question, not just return a list.

Evidence

Inspect the reasoning instead of trusting one output.

Research gets stronger when the trader can see why something qualified, what weakened it, and which assumptions are doing the work. PredictDesk is designed to make that evidence easier to inspect.

  • Review diagnostics and hypothetical behavior in context.
  • Compare alternatives without losing the original thesis.
  • Use evidence to challenge assumptions, not to outsource judgment.

Continuity

Carry the reasoning forward after the first review.

A setup does not stop mattering once the initial scan is done. PredictDesk is built to preserve context so traders can keep watching what matters while execution and account decisions remain separate.

  • Keep notes, reasoning, and review context connected.
  • Make monitoring context easier to revisit.
  • Leave order placement, custody, and account management with the broker.

Boundary

A research workflow is not a signal feed

PredictDesk supports research organization, diagnostics, hypothetical review, and monitoring context. It is not a broker, investment adviser, custodian, execution venue, signal seller, or guaranteed-performance product.

Not a broker. Not investment advice. Backtests and scenario results are hypothetical. Options involve significant risk. Waitlist signup does not create approval or access.